Bank of America Comments on Q2 for UnitedHealth Group

Bank of America has published a research report on United Health Group UNH. In the report, Bank of America wrote, "UNH reported strong Q2 earnings, with EPS of $1.16, well above our $0.97 est and the $1.04 consensus (both of which exclude Penn Treaty charges). An estimated $0.05 benefit from prior development helped, but results ex. development were still strong. Membership, MLR and SG&A all came in better than expected. More importantly, UNH raised 2011 EPS guidance to $4.15-4.25 from $3.95-4.05 (both include the $0.12-0.15 one-time Penn Treaty charge, implying new non-GAAP guidance of $4.27-4.40), although we note that guidance now includes a $0.06 benefit in the back half related to a lower tax rate." Bank of America rated UnitedHealth Group a BUY with a price target of $59.00. UnitedHealth Group closed Monday at $51.95.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorAnalyst RatingsBank of AmericaHealth CareManaged Health CareUnitedHealth Group
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!